EBV-encoded miRNAs

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1809, Issue 11-12, 2011, Pages 631-640

  Barth, Stephanie ^a   Meister, Gunter ^b   Grässer, Friedrich A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Apoptosis; BART; BHRF1; EBV; Epstein Barr virus; Gene regulation; Latency; MicroRNA; miRNA; Transformation; Tumorigenesis

Indexed keywords

MICRORNA; VIRUS RNA;

APOPTOSIS; ARTICLE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXOSOME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; HUMAN; IMMUNE EVASION; INNATE IMMUNITY; LARGE CELL LYMPHOMA; LATENT VIRUS INFECTION; NASOPHARYNX CARCINOMA; NK T CELL LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS LATENCY;

ANIMALS; CARCINOMA; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA; MICRORNAS; MODELS, GENETIC;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 80655144437     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2011.05.010     Document Type: Article

References (146)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
3. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
4. Cai X., Hagedorn C.H., Cullen B.R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004, 10:1957-1966. (Epub 2004 Nov 1953).
5. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060. (Epub 2004 Sep 4016).
6. Borchert G.M., Lanier W., Davidson B.L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006, 12:12.
7. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., Hannon G.J. Processing of primary microRNAs by the Microprocessor complex. Nature 2004, 432:231-235.
8. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
9. Han J., Lee Y., Yeom K.H., Kim Y.K., Jin H., Kim V.N. The drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004, 18:3016-3027.
10. Landthaler M., Yalcin A., Tuschl T. The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Curr. Biol. 2004, 14:2162-2167.
11. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
12. Han J., Lee Y., Yeom K.H., Nam J.W., Heo I., Rhee J.K., Sohn S.Y., Cho Y., Zhang B.T., Kim V.N. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006, 125:887-901.
13. Guil S., Caceres J.F. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat. Struct. Mol. Biol. 2007, 14:591-596.
14. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
15. Trabucchi M., Briata P., Garcia-Mayoral M., Haase A.D., Filipowicz W., Ramos A., Gherzi R., Rosenfeld M.G. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009, 459:1010-1014.
16. Bohnsack M.T., Czaplinski K., Gorlich D. Exportin 5 is a RanGTP-Dependent dsRNA-Binding Protein that Mediates Nuclear Export of Pre-miRNAs. RNA 2004, 185-191.
17. Lund E., Guttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science 2004, 303:95-98. (Epub 2003 Nov 2020).
18. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17:3011-3016.
19. Grishok A., Pasquinelli A.E., Conte D., Li N., Parrish S., Ha I., Baillie D.L., Fire A., Ruvkun G., Mello C.C. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 2001, 106:23-34.
20. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293:834-838.
21. Lee Y.S., Nakahara K., Pham J.W., Kim K., He Z., Sontheimer E.J., Carthew R.W. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 2004, 117:69-81.
22. Xie Z., Johansen L.K., Gustafson A.M., Kasschau K.D., Lellis A.D., Zilberman D., Jacobsen S.E., Carrington J.C. Genetic and functional diversification of small RNA pathways in plants. PLoS Biol. 2004, 2:E104.
23. Mourelatos Z., Dostie J., Paushkin S., Sharma A., Charroux B., Abel L., Rappsilber J., Mann M., Dreyfuss G. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 2002, 16:720-728.
24. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
25. Haase A.D., Jaskiewicz L., Zhang H., Laine S., Sack R., Gatignol A., Filipowicz W. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005, 6:961-967.
26. Lee Y., Hur I., Park S.Y., Kim Y.K., Suh M.R., Kim V.N. The role of PACT in the RNA silencing pathway. EMBO J. 2006, 25:522-532.
27. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
28. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11:228-234.
29. Hutvagner G., Simard M.J. Argonaute proteins: key players in RNA silencing. Nat. Rev. Mol. Cell Biol. 2008, 9:22-32.
30. Jinek M., Doudna J.A. A three-dimensional view of the molecular machinery of RNA interference. Nature 2009, 457:405-412.
31. Parker J.S., Barford D. Argonaute: a scaffold for the function of short regulatory RNAs. Trends Biochem. Sci. 2006, 31:622-630.
32. Peters L., Meister G. Argonaute proteins: mediators of RNA silencing. Mol. Cell 2007, 26:611-623.
33. Song J.J., Joshua-Tor L. Argonaute and RNA-getting into the groove. Curr. Opin. Struct. Biol. 2006, 16:5-11.
34. Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M., Song J.J., Hammond S.M., Joshua-Tor L., Hannon G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004, 305:1437-1441.
35. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 2004, 15:185-197.
36. Hutvagner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060. (Epub 2002 Aug 2051).
37. Voinnet O. Origin, biogenesis, and activity of plant microRNAs. Cell 2009, 136:669-687.
38. Ding L., Spencer A., Morita K., Han M. The developmental timing regulator AIN-1 interacts with miRISCs and may target the argonaute protein ALG-1 to cytoplasmic P bodies in C. elegans. Mol. Cell 2005, 19:437-447.
39. Jakymiw A., Lian S., Eystathioy T., Li S., Satoh M., Hamel J.C., Fritzler M.J., Chan E.K. Disruption of GW bodies impairs mammalian RNA interference. Nat. Cell Biol. 2005, 7:1267-1274.
40. Liu J., Rivas F.V., Wohlschlegel J., Yates J.R., Parker R., Hannon G.J. A role for the P-body component GW182 in microRNA function. Nat. Cell Biol. 2005, 7:1261-1266.
41. Meister G., Landthaler M., Peters L., Chen P.Y., Urlaub H., Luhrmann R., Tuschl T. Identification of novel argonaute-associated proteins. Curr. Biol. 2005, 15:2149-2155.
42. Rehwinkel J., Behm-Ansmant I., Gatfield D., Izaurralde E. A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 2005, 11:1640-1647.
43. Huntzinger E., Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 2011, 12:99-110.
44. Tritschler F., Huntzinger E., Izaurralde E. Role of GW182 proteins and PABPC1 in the miRNA pathway: a sense of deja vu. Nat. Rev. Mol. Cell Biol. 2010, 11:379-384.
45. Chen K., Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 2007, 8:93-103.
46. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 2004, 5:396-400.
47. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773. (Epub 2005 Jan 2030).
48. Beitzinger M., Peters L., Zhu J.Y., Kremmer E., Meister G. Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol. 2007, 4:76-84.
49. Easow G., Teleman A.A., Cohen S.M. Isolation of microRNA targets by miRNP immunopurification. RNA 2007, 13:1198-1204.
50. Karginov F.V., Conaco C., Xuan Z., Schmidt B.H., Parker J.S., Mandel G., Hannon G.J. A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19291-19296.
51. Chi S.W., Zang J.B., Mele A., Darnell R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486.
52. M. Hafner, M. Landthaler, L. Burger, M. Khorshid, J. Hausser, P. Berninger, A. Rothballer, M. Ascano, A.C. Jungkamp, M. Munschauer, A. Ulrich, G.S. Wardle, S. Dewell, M. Zavolan, T. Tuschl, PAR-CliP - a method to identify transcriptomewide the binding sites of RNA binding proteins, J. Vis. Exp. (in press), http://doi:10.3791/2034.
53. Davison A.J., Eberle R., Ehlers B., Hayward G.S., McGeoch D.J., Minson A.C., Pellett P.E., Roizman B., Studdert M.J., Thiry E. The order Herpesvirales. Arch. Virol. 2009, 154:171-177.
54. Pellett P.E., Roizman B. The family Herpesviridae: a brief introduction. Fields Virology 2007, vol. 2:2479-2499. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Strauss (Eds.).
55. Roizman B., Knipe D.M., Whitley R.J. Herpes Simplex viruses. Fields Virology 2007, 2:2500-2601. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, B. Roizman, S.E. Strauss (Eds.).
56. Kieff E., Rickinson A.E. Epstein-Barr virus and its replication. Fields Virology 2007, 2:2603-2654. Lippincott-Raven, Philadelphia.
57. Young L.S., Arrand J.R., Murray P.G. EBV gene expression and regulation. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis 2007, 1. Cambridge University Press, Cambridge.
58. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 1:702-703.
59. Bornkamm G.W. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Int. J. Cancer 2009, 124:1745-1755.
60. Delecluse H.J., Feederle R., O'Sullivan B., Taniere P. Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J. Clin. Pathol. 2007, 60:1358-1364.
61. Lim W.H., Russ G.R., Coates P.T. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology 2006, 11:355-366.
62. Miyashita E.M., Yang B., Lam K.M., Crawford D.H., Thorley-Lawson D.A. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 1995, 80:593-601.
63. Rowe M., Rowe D.T., Gregory C.D., Young L.S., Farrell P.J., Rupani H., Rickinson A.B. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 1987, 6:2743-2751.
64. Xue S.A., Labrecque L.G., Lu Q.L., Ong S.K., Lampert I.A., Kazembe P., Molyneux E., Broadhead R.L., Borgstein E., Griffin B.E. Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi. Int. J. Cancer 2002, 99:635-643.
65. Pfeffer S., Zavolan M., Grasser F.A., Chien M., Russo J.J., Ju J., John B., Enright A.J., Marks D., Sander C., Tuschl T. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
66. Cai X., Schafer A., Lu S., Bilello J.P., Desrosiers R.C., Edwards R., Raab-Traub N., Cullen B.R. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006, 2:e23. (Epub 2006 Mar 2024).
67. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields Virology 2007, 2:2655-2700. Lippincott-Raven, Philadelphia.
68. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald Mullen P.M., Klein G., Kurilla M.G., Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995, 375:685-688.
69. Zomer A., Vendrig T., Hopmans E.S., van Eijndhoven M., Middeldorp J.M., Pegtel D.M. Exosomes: fit to deliver small RNA. Commun. Integr. Biol. 2010, 3:447-450.
70. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., van Dyk L.F., Ho C.K., Shuman S., Chien M., Russo J.J., Ju J., Randall G., Lindenbach B.D., Rice C.M., Simon V., Ho D.D., Zavolan M., Tuschl T. Identification of microRNAs of the herpesvirus family. Nat. Methods 2005, 2:269-276. (Epub 2005 Feb 2016).
71. Grundhoff A., Sullivan C.S., Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006, 12:733-750. (Epub 2006 Mar 2015).
72. Cai X., Lu S., Zhang Z., Gonzalez C.M., Damania B., Cullen B.R. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5570-5575. (Epub 2005 Mar 5530).
73. Cui C., Griffiths A., Li G., Silva L.M., Kramer M.F., Gaasterland T., Wang X.J., Coen D.M. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 2006, 80:5499-5508.
74. Burnside J., Bernberg E., Anderson A., Lu C., Meyers B.C., Green P.J., Jain N., Isaacs G., Morgan R.W. Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript. J. Virol. 2006, 80:8778-8786.
75. Chen S.J., Chen G.H., Chen Y.H., Liu C.Y., Chang K.P., Chang Y.S., Chen H.C. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PloS One 2010, 5.
76. Zhu J.Y., Pfuhl T., Motsch N., Barth S., Nicholls J., Grasser F., Meister G. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J. Virol. 2009, 83:3333-3341.
77. Hutzinger R., Feederle R., Mrazek J., Schiefermeier N., Balwierz P.J., Zavolan M., Polacek N., Delecluse H.J., Huttenhofer A. Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog. 2009, 5:e1000547.
78. Edwards R.H., Marquitz A.R., Raab-Traub N. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J. Virol. 2008, 82:9094-9106.
79. Hitt M.M., Allday M.J., Hara T., Karran L., Jones M.D., Busson P., Tursz T., Ernberg I., Griffin B.E. EBV gene expression in an NPC-related tumour. EMBO J. 1989, 8:2639-2651.
80. Gilligan K., Sato H., Rajadurai P., Busson P., Young L., Rickinson A., Tursz T., Raab-Traub N. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J. Virol. 1990, 64:4948-4956.
81. Smith P.R., Gao Y., Karran L., Jones M.D., Snudden D., Griffin B.E. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J. Virol. 1993, 67:3217-3225.
82. Smith P.R., de Jesus O., Turner D., Hollyoake M., Karstegl C.E., Griffin B.E., Karran L., Wang Y., Hayward S.D., Farrell P.J. Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J. Virol. 2000, 74:3082-3092.
83. Pratt Z.L., Kuzembayeva M., Sengupta S., Sugden B. The microRNAs of Epstein-Barr virus are expressed at dramatically differing levels among cell lines. Virology 2009, 386:387-397.
84. Nanbo A., Sugden A., Sugden B. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J. 2007, 26:4252-4262.
85. Motsch N., Pfuhl T., Mrazek J., Barth S., Grasser F.A. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 2007, 4:131-137.
86. Cameron J.E., Yin Q., Fewell C., Lacey M., McBride J., Wang X., Lin Z., Schaefer B.C., Flemington E.K. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 2008, 82:1946-1958.
87. Lee J.E., Hong E.J., Nam H.Y., Kim J.W., Han B.G., Jeon J.P. MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits. Cell Prolif. 2011, 44:59-66.
88. Tam W., Dahlberg J.E. miR-155/BIC as an oncogenic microRNA. Genes Chromosomes Cancer 2006, 45:211-212.
89. Mrazek J., Kreutmayer S.B., Grasser F.A., Polacek N., Huttenhofer A. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res. 2007, 3:3.
90. Kluiver J., Haralambieva E., de Jong D., Blokzijl T., Jacobs S., Kroesen B.J., Poppema S., van den Berg A. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 2006, 45:147-153.
91. Cameron J.E., Fewell C., Yin Q., McBride J., Wang X., Lin Z., Flemington E.K. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 2008, 382:257-266.
92. Gatto G., Rossi A., Rossi D., Kroening S., Bonatti S., Mallardo M. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res. 2008, 36:6608-6619.
93. Rahadiani N., Takakuwa T., Tresnasari K., Morii E., Aozasa K. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem. Biophys. Res. Commun. 2008, 377:579-583.
94. Lu F., Weidmer A., Liu C.G., Volinia S., Croce C.M., Lieberman P.M. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J. Virol. 2008, 82:10436-10443.
95. Cosmopoulos K., Pegtel M., Hawkins J., Moffett H., Novina C., Middeldorp J., Thorley-Lawson D.A. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 2009, 83:2357-2367.
96. Kim do N., Chae H.S., Oh S.T., Kang J.H., Park C.H., Park W.S., Takada K., Lee J.M., Lee W.K., Lee S.K. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J. Virol. 2007, 81:1033-1036.
97. Imig J., Motsch N., Zhu J.Y., Barth S., Okoniewski M., Reineke T., Tinguely M., Faggioni A., Trivedi P., Meister G., Renner C., Grässer F.A. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res. 2011, 39:1880-1893.
98. Navarro A., Gaya A., Martinez A., Urbano-Ispizua A., Pons A., Balague O., Gel B., Abrisqueta P., Lopez-Guillermo A., Artells R., Montserrat E., Monzo M. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 2008, 111:2825-2832.
99. Van Vlierberghe P., De Weer A., Mestdagh P., Feys T., De Preter K., De Paepe P., Lambein K., Vandesompele J., Van Roy N., Verhasselt B., Poppe B., Speleman F. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs. Br. J. Haematol. 2009, 147:686-690.
100. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2257-2261. (Epub 2006 Feb 2253).
101. Lin Z., Wang X., Fewell C., Cameron J., Yin Q., Flemington E.K. Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429. J. Virol. 2010, 84:7892-7897.
102. Ellis-Connell A.L., Iempridee T., Xu I., Mertz J.E. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J. Virol. 2010, 84:10329-10343.
103. Shinozaki A., Sakatani T., Ushiku T., Hino R., Isogai M., Ishikawa S., Uozaki H., Takada K., Fukayama M. Downregulation of microRNA-200 in EBV-associated gastric carcinoma. Cancer Res. 2010, 70:4719-4727.
104. Bellan C., Lazzi S., Hummel M., Palummo N., de Santi M., Amato T., Nyagol J., Sabattini E., Lazure T., Pileri S.A., Raphael M., Stein H., Tosi P., Leoncini L. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 2005, 106:1031-1036.
105. Leucci E., Onnis A., Cocco M., De Falco G., Imperatore F., Giuseppina A., Costanzo V., Cerino G., Mannucci S., Cantisani R., Nyagol J., Mwanda W., Iriso R., Owang M., Schurfeld K., Bellan C., Lazzi S., Leoncini L. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int. J. Cancer 2010, 126:1316-1326.
106. Farazi T.A., Spitzer J.I., Morozov P., Tuschl T. miRNAs in human cancer. J. Pathol. 2011, 223:102-115.
107. Di Leva G., Croce C.M. Roles of small RNAs in tumor formation. Trends Mol. Med. 2010, 16:257-267.
108. Spizzo R., Nicoloso M.S., Croce C.M., Calin G.A. SnapShot: microRNAs in cancer. Cell 2009, 137(3). 586-586.
109. Tan L.P., Wang M., Robertus J.L., Schakel R.N., Gibcus J.H., Diepstra A., Harms G., Peh S.C., Reijmers R.M., Pals S.T., Kroesen B.J., Kluin P.M., Poppema S., van den Berg A. miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Lab. Invest. 2009, 89:708-716.
110. Thomas M.D., Kremer C.S., Ravichandran K.S., Rajewsky K., Bender T.P. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 2005, 23:275-286.
111. Jang K.L., Shackelford J., Seo S.Y., Pagano J.S. Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18431-18436.
112. Xia T., O'Hara A., Araujo I., Barreto J., Carvalho E., Sapucaia J.B., Ramos J.C., Luz E., Pedroso C., Manrique M., Toomey N.L., Brites C., Dittmer D.P., Harrington W.J. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008, 68:1436-1442.
113. Amoroso R., Fitzsimmons L., Thomas W.A., Kelly G.L., Rowe M., Bell A.I. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. J. Virol. 2011, 85:996-1010.
114. Harabuchi Y., Takahara M., Kishibe K., Moriai S., Nagato T., Ishii H. Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. Int. J. Clin. Oncol. 2009, 14:181-190.
115. Aozasa K., Takakuwa T., Hongyo T., Yang W.I. Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int. J. Hematol. 2008, 87:110-117.
116. Godshalk S.E., Bhaduri-McIntosh S., Slack F.J. Epstein-Barr virus-mediated dysregulation of human microRNA expression. Cell Cycle 2008, 7:3595-3600.
117. Iizasa H., Wulff B.E., Alla N.R., Maragkakis M., Megraw M., Hatzigeorgiou A., Iwakiri D., Takada K., Wiedmer A., Showe L., Lieberman P., Nishikura K. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J. Biol. Chem. 2010, 285:33358-33370.
118. Paschos K., Smith P., Anderton E., Middeldorp J.M., White R.E., Allday M.J. Epstein-Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog. 2009, 5:e1000492.
119. Kempkes B., Spitkovsky D., Jansen Durr P., Ellwart J.W., Kremmer E., Delecluse H.J., Rottenberger C., Bornkamm G.W., Hammerschmidt W. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J. 1995, 14:88-96.
120. Furnari F.B., Adams M.D., Pagano J.S. Unconventional processing of the 3' termini of the Epstein-Barr virus DNA polymerase mRNA. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:378-382.
121. Barth S., Pfuhl T., Mamiani A., Ehses C., Roemer K., Kremmer E., Jaker C., Hock J., Meister G., Grasser F.A. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res. 2008, 36:666-675.
122. Lo A.K., To K.F., Lo K.W., Lung R.W., Hui J.W., Liao G., Hayward S.D. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16164-16169.
123. Lung R.W., Tong J.H., Sung Y.M., Leung P.S., Ng D.C., Chau S.L., Chan A.W., Ng E.K., Lo K.W., To K.F. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 2009, 11:1174-1184.
124. Fossum E., Friedel C.C., Rajagopala S.V., Titz B., Baiker A., Schmidt T., Kraus T., Stellberger T., Rutenberg C., Suthram S., Bandyopadhyay S., Rose D., von Brunn A., Uhlmann M., Zeretzke C., Dong Y.A., Boulet H., Koegl M., Bailer S.M., Koszinowski U., Ideker T., Uetz P., Zimmer R., Haas J. Evolutionarily conserved herpesviral protein interaction networks. PLoS Pathog. 2009, 5:e1000570.
125. Bailer S.M., Haas J. Connecting viral with cellular interactomes. Curr. Opin. Microbiol. 2009, 12:453-459.
126. Granato M., Feederle R., Farina A., Gonnella R., Santarelli R., Hub B., Faggioni A., Delecluse H.J. Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles. J. Virol. 2008, 82:4042-4051.
127. Seto E., Moosmann A., Gromminger S., Walz N., Grundhoff A., Hammerschmidt W. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog. 2010, 6.
128. Tang S., Bertke A.S., Patel A., Margolis T.P., Krause P.R. Herpes Simplex virus-2 miR-H6 is a Novel LAT-associated microRNA, but reduction of its expression does not influence viral latency establishment or recurrence phenotype. J. Virol. 2011, 85:4501-4509.
129. Choy E.Y., Siu K.L., Kok K.H., Lung R.W., Tsang C.M., To K.F., Kwong D.L., Tsao S.W., Jin D.Y. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med. 2008, 205:2551-2560.
130. Walz N., Christalla T., Tessmer U., Grundhoff A. A global analysis of evolutionary conservation among known and predicted gammaherpesvirus microRNAs. J. Virol. 2010, 84:716-728.
131. Kvansakul M., Wei A.H., Fletcher J.I., Willis S.N., Chen L., Roberts A.W., Huang D.C., Colman P.M. Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1. PLoS Pathog. 2010, 6:e1001236.
132. Marquitz A.R., Mathur A., Nam C.S., Raab-Traub N. The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology 2011, 412(2):392-400.
133. Dolken L., Malterer G., Erhard F., Kothe S., Friedel C.C., Suffert G., Marcinowski L., Motsch N., Barth S., Beitzinger M., Lieber D., Bailer S.M., Hoffmann R., Ruzsics Z., Kremmer E., Pfeffer S., Zimmer R., Koszinowski U.H., Grasser F., Meister G., Haas J. Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 2010, 7:324-334.
134. Gorlich D., Dabrowski M., Bischoff F.R., Kutay U., Bork P., Hartmann E., Prehn S., Izaurralde E. A novel class of RanGTP binding proteins. J Cell Biol. 1997, 138:65-80.
135. Saeki K., Suzuki H., Tsuneoka M., Maeda M., Iwamoto R., Hasuwa H., Shida S., Takahashi T., Sakaguchi M., Endo T., Miura Y., Mekada E., Mihara K. Identification of mammalian TOM22 as a subunit of the preprotein translocase of the mitochondrial outer membrane. J. Biol. Chem. 2000, 275:31996-32002.
136. Yano M., Hoogenraad N., Terada K., Mori M. Identification and functional analysis of human Tom22 for protein import into mitochondria. Mol.Cell. Biol. 2000, 20:7205-7213.
137. Yang I.V., Wade C.M., Kang H.M., Alper S., Rutledge H., Lackford B., Eskin E., Daly M.J., Schwartz D.A. Identification of novel genes that mediate innate immunity using inbred mice. Genetics 2009, 183:1535-1544.
138. Huang R.S., Hu G.Q., Lin B., Lin Z.Y., Sun C.C. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J. Investig. Med. 2010, 58:961-967.
139. Nachmani D., Stern-Ginossar N., Sarid R., Mandelboim O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 2009, 5:376-385.
140. Skalsky R.L., Samols M.A., Plaisance K.B., Boss I.W., Riva A., Lopez M.C., Baker H.V., Renne R. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 2007, 81:12836-12845.
141. Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W.H., Chi J.T., Braich R., Manoharan M., Soutschek J., Ohler U., Cullen B.R. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007, 450:1096-1099.
142. Zhao Y., Yao Y., Xu H., Lambeth L., Smith L.P., Kgosana L., Wang X., Nair V. A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J. Virol. 2009, 83:489-492.
143. Gourzones C., Gelin A., Bombik I., Klibi J., Verillaud B., Guigay J., Lang P., Temam S., Schneider V., Amiel C., Baconnais S., Jimenez A.S., Busson P. Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol. J. 2010, 7:271.
144. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., de Gruijl T.D., Wurdinger T., Middeldorp J.M. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6328-6333.
145. Meckes D.G., Shair K.H., Marquitz A.R., Kung C.P., Edwards R.H., Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:20370-20375.
146. Ascherio A., Munger K.L. Epstein-Barr virus infection and multiple sclerosis: a review. J. Neuroimmune Pharmacol. 2010, 5:271-277.